IPO News
Rubicon Research IPO is open for public subscription from October 9, 2025 till October 13, 2025. The IPO comprises of a fresh issue and an OFS, with a price band of Rs.461- Rs.485 per equity share.
Rubicon Research Limited: IPO Details at a Glance
• IPO Opens: October 9, 2025
• IPO Closes: October 13, 2025
• IPO Price Band: Rs.461 – Rs.485 per equity share
• Fresh Issue: Around Rs.500 crore
• Offer for Sale (OFS): Around Rs.877.5 crore
• Discount for Eligible Employees: Rs.46 per equity share
• Lot Size: 30 shares
• Min. Retail Investment Amount: Rs.13,830 (at upper band)
• Max. Retail Subscription Amount: Rs.2,00,000
• Max. Subscription (Employees): Rs.5,00,000
• Listing At Stock Exchange: NSE and BSE
• Registrar of the IPO: MUFG Intime India Private Limited
• Book Running Lead Managers: Axis Capital, IIFL Capital Services, JM Financial, SBI Capital Markets
• Sponsor Banks of the Issue: HDFC Bank, Axis Bank
Rubicon Research IPO: Subscription Details
As of Day 2, the IPO has been subscribed 2.37 times overall. Segment-wise investors participation:
• Total Subscription: 2.37x
• Retail Individual Investors: 3.94x
• Retail Investors (Employees): 2.21x
• Qualified Institutional Buyers (QIBs): 2.11x
• Non-Institutional Investors (NIIs): 1.82x
Rubicon Research IPO: Company Overview
Rubicon Research, an India pharmaceutical company, is into development and manufacturing of specialised products and drug-device combinations, basically for the markets in US. The company has its own Research and Development labs and cGMP compliant manufacturing plant, aims at innovation, excellence, and process improvements.
Disclaimer: The above article is only for the purpose of information. It does not constitute financial guidance in any form(s). Investors here are suggested to carefully review the prospectus and refer to a registered financial advisor or certified investment professional before they finalise any investment. Similarly, past performances are not an indication of future outcomes. Investments are subject to market risks.
Also Read: Muhurat Trading 2025: This One Hour On Diwali Could Change Your Wealth Forever
Ankur Mishra is a journalist who covers an extensive range of news, from business, stock markets, IPOs to geopolitics, world affairs, international crises, and general news. With over a decade of experience in the business domain, Ankur has been associated with some of the reputed media brands. Through a sharp eye on global marketplaces along with deep insights and analysis of business strategies, Ankur brings simplicity to the complex economic matrix to decode market trends and empower people.
He is committed to entrenched data, facts, research, solutions, and a dedication to value-based journalism. He has covered trade tariff wars, international alliances, corporate policies, government initiatives, regulatory developments, along with micro- and macroeconomic shifts impacting global fiscal dynamics.
Delhi NCR experiences relief as CAQM cancels GRAP measures; AQI improves to 119 thanks to…
Ishqan De Lekhe OTT Release Soon: Isha Malviya’s Romantic Journey, Find Out When And Where To Watch!
Ishqan De Lekhe is a touching Punjabi romantic drama starring Gurnam Bhullar and Isha Malviya.…
A drone hit the Royal Tulip Al-Rasheed Hotel in Baghdad’s Green Zone, causing fires and…
